Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 614 participants.
Also called NCT01300013
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 614 participants
- Sponsor
- Registry
-
NCT01300013
-
- Other papers using this trial's data
- Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Lithuania, Netherlands, Norway, Poland, Russia, Slovakia, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01300013. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF)
- Condition
- Heart Failure
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Omecamtiv mecarbil
- Lead sponsor
- Cytokinetics
Record details
- Record id
cardio:ct-nct01300013- Content hash
b85e83eb13f5c2a76553596c66a6f72e423ef260bed15192edd8fb5a136656c9